Early assessment of pre-radiation therapy financial toxicity in prostate cancer from the navigator-assisted hypofractionation (NAVAH) clinical trial.
335 Background: Prostate cancer (PC) is the most common malignancy among men, and one of the leading causes of cancer-related mortality in the United States. Financial toxicity (FT) is defined as the harmful economic burden and financial distress associated with medical care. Patients at high risk of PC-related...